This is a community-generated profile. If you would like to claim it, please .
Keros Therapeutics
Develops treatments for hematologic & musculoskeletal disorders51-200 EmployeesActively Hiring
Keros Therapeutics Funding
$140M
11 round
Keros Therapeutics is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $140M. Their most recent funding was raised on January 3, 2024.
Funding Rounds
S
$140000000